Back to Search
Start Over
Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panel.
- Source :
-
The lancet. HIV [Lancet HIV] 2022 Nov; Vol. 9 (11), pp. e791-e800. Date of Electronic Publication: 2022 Oct 11. - Publication Year :
- 2022
-
Abstract
- New tuberculosis vaccine candidates that are in the development pipeline need to be studied in people with HIV, who are at high risk of acquiring Mycobacterium tuberculosis infection and tuberculosis disease and tend to develop less robust vaccine-induced immune responses. To address the gaps in developing tuberculosis vaccines for people with HIV, a series of symposia was held that posed six framing questions to a panel of international experts: What is the use case or rationale for developing tuberculosis vaccines? What is the landscape of tuberculosis vaccines? Which vaccine candidates should be prioritised? What are the tuberculosis vaccine trial design considerations? What is the role of immunological correlates of protection? What are the gaps in preclinical models for studying tuberculosis vaccines? The international expert panel formulated consensus statements to each of the framing questions, with the intention of informing tuberculosis vaccine development and the prioritisation of clinical trials for inclusion of people with HIV.<br />Competing Interests: Declaration of interests We declare no competing interests.<br /> (Copyright © 2022 Elsevier Ltd. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 2352-3018
- Volume :
- 9
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- The lancet. HIV
- Publication Type :
- Academic Journal
- Accession number :
- 36240834
- Full Text :
- https://doi.org/10.1016/S2352-3018(22)00255-7